PRRT2 and colonic neoplasm: Simultaneous activation of PKC/p38 and EGFR/ERK signaling potentiates MMP-1 gene and protein expression, and augments colon cancer cell invasion while blocking MMP-1 activity abolishes M3R agonist-induced colon cancer cell invasion [34].